# Parecoxib

## Dynastat inj 40mg

| TAH Drug Code      | [IDYN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IDYN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Short-term use (not exceeding four days) for the relief of postoperative pain.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Adults: Initial dose: 40mg IV/IM, followed by 20mg Q12H or Q24H. IM: Slowly inject into the deep part of the muscle. The current clinical experience with Dynastat for more than three days is limited. Because the cardiovascular risk of the second type cyclooxygenase-2 (COX-2) specific inhibitor may increase with the increase of the dose, try to shorten the treatment period and use the lowest effective dose. Elders: >=65 years old: Generally do not need to adjust the dose. <50kg: The initial dose should be half of the general recommended dose. maximum dose:40mg/day. Children and teenagers: Not recommended. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Hypersensitivity to parecoxib or sulfonamides. Active peptic ulceration or GI bleeding, inflammatory bowel disease, CHF (NYHA II-IV), severe hepatic dysfunction (serum albumin <25 g/L or Child-Pugh score >=10). Patients who have experienced asthma, urticaria or allergic-type reactions to aspirin or NSAIDs including selective COX-2 inhibitors. Treatment of post-op pain immediately following CABG surgery. Established ischemic heart disease, peripheral arterial disease &/or cerebrovascular disease. Pregnancy (3rd trimester) & lactation.                                                                         |
| Adverse Effects    | Nausea. Abdominal pain, constipation, dyspepsia, vomiting; peripheral edema; alveolar osteitis (dry socket); dizziness; insomnia; oliguria; increased sweating, pruritis; hypotension.                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/parecoxib-international-drug-information-concise)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

